Endocrine Society GUIDELINES Bundle (free trial)

Metabolic Risk

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/302967

Contents of this Issue

Navigation

Page 11 of 17

Treatment 12 Table 4. Effect of Lifestyle Components on Metabolic Parameters Intervention Glycemic/Diabetes Effect Blood Pressure Effect Lipids Effect Moderate weight loss ≥5% of initial weight (Rec. 3.1.1) 30–60% reduction in diabetes incidence 1 Effect on glycemic indices 2 : • Reduction in HbA1c ~0.6 units • Reduction in fasting glucose ~0.2 mmol/L (3.6 mg/dL) BP reduction about 3/2 mmHg 1,2 • Reduction in TGL 1,2 : 15–16 mg/dL (0.17–0.18 mmol/L) • Reduction in LDL 1,2 : 5–10 mg/dL (0.13–0.26 mmol/L) • Increase in HDL 1,2 : 4–31 mg/dL (0.1–0.8 mmol/L) Healthy cardiovascular dietary patterns (Rec. 3.1.2) Reduction 18–40% in diabetes incidence (Mediterranean diet) 3 BP reduction ≤6/3 mmHg (based on DASH diet) 1 • Trans fat: repeatedly associated with adverse lipid profile 1 • DASH diet: lower LDL and total cholesterol 1 • Mediterranean diet: inconsistent findings 1 Active lifestyle (Rec. 3.1.3) Reduction of ≤65% in diabetes incidence 4,5 BP reduction about 2–5/ 1–4 mmHg 1,6 Reduction in LDL about 3.0–6.0 mg/dL (0.08–0.16 mmol/L) 1 Note: Ranges taken om systematic reviews and meta-analyses as listed below. 1 Lifestyle Work Group. Lifestyle Interventions to Reduce Cardiovascular Risk: Systematic Evidence Review from the Lifestyle Work Group. National Heart, Lung, and Blood Institute; December 2013. 2 Zomer E, Gurusamy K, Leach R, Trimmer C, Lobstein T, Morris S, James WP, Finer N. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev 2016; 17(10):1001-1011. 3 Salas-Salvado J, Bullo M, Estruch R, Ros E, Covas MI, Ibarrola-Jurado N, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Romaguera D, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez-Gonzalez MA. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med 2014; 160(1): 1-10. 4 Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. e Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4):537-544. 5 Laaksonen DE, Lindstrom J, Lakka TA, Eriksson JG, Niskanen L, Wikstrom K, Aunola S, Keinanen-Kiukaanniemi S, Laakso M, Valle TT, Ilanne-Parikka P, Louheranta A, Hamalainen H, Rastas M, Salminen V, Cepaitis Z, Hakumaki M, Kaikkonen H, Harkonen P, Sundvall J, Tuomilehto J, Uusitupa M. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005; 54(1):158-165. 6 2018 Physical Activity Guidelines Advisory Committee, 2018 Physical Activity Guidelines Advisory Committee Scien-tific Report, Washington, DC: U.S. Department of Health and Human Services.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Metabolic Risk